Dr. Edwin Kojo Ogara, the Technical Officer for Essential Drugs and Medicines at the World Health Organization-Kenya Country Office, paid a courtesy call to Kenya BioVax Institute Limited, where he was received by the acting CEO Dr. Cecilia Wanjala alongside representatives of the technical team. The meeting at BioVax headquarters provided a platform for discussions on strengthening collaborations in vaccine manufacturing, essential medicines, and regulatory compliance. Dr. Ogara commended BioVax’s strides in advancing local vaccine production and reaffirmed World Health Organization’s commitment to supporting initiatives that enhance Kenya’s self-sufficiency in healthcare solutions.
The engagement underscored the shared vision of fostering sustainable and resilient health systems through strategic partnerships.
